Acadia Healthcare Company, Inc.

1. 01

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +11.1% (SPY −1.6%, XLV +13.5%). 3 months: 0.0% (SPY −0.4%, XLV +15.5%). 1 year: +56.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: ACHC, SPY and XLV · as of 4 Nov 2026

2. 02

   13.7 days to cover short interest

   20.9M shares were sold short at the 15 Oct 2026 settlement, 22.5% of the 93.1M shares outstanding; covering them would take 13.7 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

3. 03

   Volume 3.2× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 5.1M shares was 3.2× the average of the 30 sessions before it (1.6M), as the price rose 8.9%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

4. 04

   10.0% below its 52-week high

   Closed at $32.25 on 4 Nov 2026: 10.0% below the 52-week high of $35.83 (22 Jul 2026) and 182.2% above the low of $11.43 (15 Jan 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $32.25 was 10.5% above its 50-day average ($29.18) and 23.7% above its 200-day average ($26.06). It has closed above the 200-day for 176 sessions, since 25 Feb 2026. The 50-day average crossed above the 200-day on 8 Apr 2026, 146 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

At the 4 Nov 2026 close